Pulmonary hypertension in patients with systemic sclerosis with CREST-syndrome and without it


如何引用文章

全文:

详细

Aim. To study incidence rate and characteristics of pulmonary hypertension development in patients with systemic sclerosis (SS).
Material and methods. The study included 31 SS patients (30 females, 1 male, age 33-75 years mean age 47.7+1.7 years).
Results. Pulmonary hypertension occurred more frequently in SS patients with CREST-syndrome than in SS patients free of this syndrome. SS patients with CREST-syndrome had also more severe ventricular hypertrophy than ventricular dilation.
Conclusion. Echocardiography proved to be a highly informative method for detection of pulmonary hypertension in patients with SS. The necessity of hemodynamical study in SS patients is emphasized.

作者简介

N Karoli

Саратовский государственный медицинский университет

Саратовский государственный медицинский университет

A Rebrov

Саратовский государственный медицинский университет

Саратовский государственный медицинский университет

E Orlova

Саратовский государственный медицинский университет

Саратовский государственный медицинский университет

参考

  1. Гусева Н. Г. Системная склеродермия и псевдосклеродер мические синдромы. М.: Медицина; 1993.
  2. Fagan К. A., Collier D. H., Badesch D. В. Scleroderma-associ ated pulmonary hypertension who's at rick and why. Advance in pulmonary hypertension. www.Phassociation.org/medical, Advances_in_PH/.../Scleroderma-Associated_PH.as
  3. Rockall A. G., Rickards D., Shaw P. J. Imaging of the pulmonary manifestation of systemic disease. Postgrad. Med. J. 2001 77:621-638.
  4. Lee P., Langevilz P., Alderdice С. et al. Mortality in systemic sclerosis (scleroderma). Quart. J. Med. 1992; 82: 139-148.
  5. Steen V., Owens G., Fino G. et al. Pulmonary involvement ir systemic sclerosis (scleroderma). Arthr. and Rheum. 1985; 28 759-767.
  6. Minai O. A., Dweik R. A., Arroliga A. C. Manifestations of scleroderma pulmonary disease. Clin. Chest Med. 1998; 19: 713- 731.
  7. MacGregor A. J, Canavan R., Knight С. et al. Pulmonary hypertension in systemic sclerosis: risk factor for progression and consequences for survival. Rheumatology 2001; 40: 453-459.
  8. Murata I., Kihara H., Shinohara S. et al. Echocardiography evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndomes. Jpn. Cire J. 1992; 56: 983-991.
  9. Stupi A. M., Steen V. D., Owens G. R. et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthr. and Rheum. 1986; 29: 515-524.
  10. Yousem S. A. The pulmonary pathologic manifestations of the CREST syndrome. Hum. Pathol. 1990; 21: 467-474.
  11. Battle R. W., Davitt M. A., Cooper S. M. et al. Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 1996; 110: 1515-1519.
  12. Hoeper M. M. Pulmonary hypertension in collagen vascular disease. Eur. Respir. J. 2002; 19: 571-576.
  13. Yamane K., Ihn H., Asano Y. et al. Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology 2000; 39: 1269-1271.
  14. Шиллер Н., Осипов М. А. Клиническая эхокардиография. M.; 1993.
  15. Ungerer R. G., Tashkin D. P., Furst D. et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progression systemic sclerosis. Am. J. Med. 1983; 75: 65-74.
  16. D'Angelo W., Fries J., Masi A. et al. Pathologic observations in systemic sclerosis (scleroderma). Am. J. Med. 1969; 46: 428- 440.
  17. Koh E. Т., Lee P., Gladman D. D., Abu-Shakra M. Pulmonary hypertension in systemic sclerosis an analysis of 17 patients. Br. J. Rheumatol. 1996; 35: 989-993.
  18. Насонова В. А., Астапенко М. Г. Клиническая ревматология: Руководство для врачей. М.: Медицина; 1989. 175- 197.

版权所有 © Consilium Medicum, 2004

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 
 


##common.cookie##